Portal de Periódicos da CAPES

A REVIEW OF BIOCHEMICAL CHANGES INDUCED IN VIVO BY LYSERGIC ACID DIETHYLAMIDE AND SIMILAR DRUGS

1957; Wiley; Volume: 66; Issue: 3 Linguagem: Inglês

10.1111/j.1749-6632.1957.tb40740.x

1749-6632

Hudson Hoagland,

Chemical synthesis and alkaloids

Annals of the New York Academy of SciencesVolume 66, Issue 3 p. 445-458 A REVIEW OF BIOCHEMICAL CHANGES INDUCED IN VIVO BY LYSERGIC ACID DIETHYLAMIDE AND SIMILAR DRUGS Hudson Hoagland, Hudson Hoagland Worcester Foundation for Experimental Biology, Shrewsbury, Mass.Search for more papers by this author Hudson Hoagland, Hudson Hoagland Worcester Foundation for Experimental Biology, Shrewsbury, Mass.Search for more papers by this author First published: March 1957 https://doi.org/10.1111/j.1749-6632.1957.tb40740.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kallmann, J. 1953. Heredity in Health and Disease. W. W. Norton. New York , N. Y. . 2 Hoagland, H. 1956. Neuropharmacology. Trans. 2nd Conf. Josiah Macy, Jr. Foundation. New York , N. Y. . 3 Boyd, E. S., E. Rothlin, J. F. Bonner, I. H. Slater & H. C. Hodge 1955. Preliminary studies on the metabolism of lysergic acid diethylamide. J. Pharmacol. Exptl. Therap. 113: 6. 4 Lanz, U., A Cerletti & E. Rothlin 1955. Über die Verteilung des Lysergsäure-diathylamids im Organismus. Helv. Physiol. et Pharmacol. Acta. 13: 207. 5 Forrer, G. R. & R. D. Goldner 1951. Experimental physiological studies with lysergic acid diethylamide. Arch. Neurol. Psychiat. 65: 581. 6 Fischer, R., F. Georgi & R. Weber 1951. Psychophysische Korrelationen. VIII. Modellversuche zum Schizophrenieproblem; Lysergsäurediäthylamid und Mezcalin. Schweiz. med. Wochschr. 81: 817, 837. 7 Mayer-Gross, W., W. McAdam & J. W. Walker 1951. Psychological and biochemical effects of lysergic acid diethylamide. Nature. 168: 827. 8 Mayer-Gross, W., W. McAdam & J. W. Walker 1953. Further observations on the effects of lysergic acid diethylamide. J. Mental Sci. 99: 804. 9 Mayer-Gross, W., W. McAdam & J. W. Walker 1952. Lysergsäurediathylamid und Kohlenhydratstoffwechsel. Nervenarzt. 23: 30. 10 Liddell, D. W. & H. Weyl-Malherbe 1953. The effects of methedrine and of lysergic acid diethylamide on mental processes and on the blood adrenaline level. J. Neurol. (Brit.). 16: 7. 11 Sloane, B. & J. W. L. Doust 1954. Psychophysiological investigations in experimental psychoses: results of the exhibition Of d-lysergic acid diethylamide to psychiatric patients. J. Mental Sci. 100: 129. 12 Elmadjian, F., J. Hope & E. Lamson Studies of the action of LSD. In preparation. 13 Graham, J. D. P. & A. I. Khalidi 1954. The actions of d-lysergic acid diethylamide (LSD 25). Part 1. General pharmacology. J. Fac. Med. Iraq. 18: 1. 14 Katzenelbogen, S. & A. D. Fang 1953. Narcosynthesis effects of sodium amytal methedrine and LSD-25. Diseases Nervous System. 14: 85. 15 Buscaino, G. A. & N. Frongia 1953. Modificazioni biochimiche, electroencefalografiche, istochimiche ed istopatologiche, in cani, durante l'intossicazione sperimentale acuta e cronica da dietilamide dell'acido lisergico. Acta Neurol. (Naples). 8: 641. 16 Anderson, E. W. & K. Rawnsley 1954. Clinical studies of lysergic acid diethylamide. Monatsschr. Psychiat. Neurol. 128: 38. 17 Freeman, H. & F. Elmadjian 1950. Carbohydrate and lymphoid studies in schizophrenia. Am. J. Psychiat. 106: 660. 18 Condrau, G. 1949. Klinische Erfahrungen an Geisteskranken mit Lysergsäure-Diäthylamid. Acta Psychiat. et Neurol. Scand. 24: 9. 19 Belsanti, R. 1952. Modificazioni neuro-psicho-biochimiche indotte dalla dietilamide dell'acido lisergico in schizofranici e frenastenici. Acta Neurol. (Naples). 7: 340. 20 Savage, C. C. Variations in ego feeling induced by d-lysergic acid diethylamide (LSD-25). Psychoanal. Rev. 42: 1. 21 Cline, H. L. & H. Freeman Studies of action of LSD. In preparation. 22 Isbell, H., H. F. Fraser, A. Wilker & R. E. Belleville 1955. Tolerance to diethylamide of lysergic acid (LSD-25). Federation Proc. 14: 354. 23 Hoagland, H., M. Rinkel, & R. W. Hyde 1955. Adrenocortical function and urinary phosphate excretion. Comparison in schizophrenia and in lysergic acid diethylamide-induced psychotic episodes in normal persons. Arch. Neurol. Psychiat. 73: 100. 24 Bergen, J. R. & N. E. Beisaw 1956. LSD and urinary inorganic phosphate excretion. Federation Proc. 16: 15. 25 Pincus, G. & H. Hoagland 1950. Adrenal cortical responses to stress in normal men and in those with personality disorders: some stress responses in normal and psychotic subjects. Am. J. Psychiat. 106: 641. 26 Haldane, J. B. S., V. B. Wigglesworth & C. E. Woodrow 1924. Proc. Roy. Soc. (London). B. 96: 1. 27 ÖRstrom, A. 1951. Isolation of phosphoglycolic acid from human erythrocytes. Arch. Biochem. and Biophys. 33: 484. 28 ÖRström, A. & O. Squag 1950. Isolation from the blood of chronic schizophrenic patients of compounds active in radioactive phosphate turnover. Acta Psychiat. et Neurol. Scand. 25: 437. 29 Boszormenyo-Nagy, I. & F. J. Gerty 1955. Diagnostic aspects of a study of intracellular phosphorylations in schizophrenia. Am. J. Psychiat. 112: 11. 30 Verzar, F. 1953. Adrenal cortex and carbohydrate phosphorylation. Ciba Foundation Colloquium on Endocrinology. 6. J. & A. Churchill. London, England. 31 Hoagland, H. 1947. Enzyme kinetics and the dynamics of behavior. J. Comp. and Physiol. Psychol. 40: 107. 31a Udenfriend, S., E. Titus, H. Weissbach & R. E. Peterson 1956. Biogenesis and metabolism of 5-hydroxyindole compounds. J. Biol. Chem. 219: 335. 32 Quastel, J. H. & A. H. M. Wheatley 1933. Effects of amines on oxidations of the brain. Biochem. J. 27: 1609. 33 Mann, P. J. G. & J. H. Quastel 1940. Benzedrine (β-phenylisopropylamine) and brain metabolism. Biochem. J. 34: 414. 34 Osmond, H. & J. Smythies 1952. Schizophrenia: a new approach I.. J. Mental Sci. 98: 309. 35 Hoffer, A., H. Osmond & J. Smythies 1954. Schizophrenia: a new approach II.. J. Mental Sci. 100: 29. 36 Meyerhof, O. & L. O. Randall Inhibitory effects of adrenochrome on cell metabolism. Arch. Biochem. 17: 171. 37 Heirman, P. 1937. L'adrénoxine, adrénaline oxydée inhibitrice. Compt. rend. Soc. biol. 126: 1264. 38 Vogt, M. 1954. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. 123: 451. 39 Woolley, D. W. & E. Shaw 1954. Some neurophysiological aspects of serotonin. Brit. Med. J. 1964 (ii): 122. 40 Gaddum, J. H. 1953. Drugs antagonistic to 5-hydroxytryptamine. Ciba Foundation Symposium on Hypertension. J. & A. Churchill. London , England . 41 Amin, A. H., T. B. B. Crawford & J. H. Gadum 1953. The distribution of 5-hydroxytryptamine and substance P in the central nervous system. Intern. Physiol. Congr. Abst. : 165. 42 Twarog, B. M. & I. H. Page 1953. Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 175: 157. 43 Brodie, B. B., A Pletscher & P. A. Shore 1955. Evidence that serotonin has a role in brain function. Science. 122: 968. 44 Pletscher, A., P. A. Shore & B. B. Brodie 1955. Serotonin release as a possible mechanism of reserpine action. Science. 122: 374. 45 Shore, P. A., A. Carlsson & B. B. Brodie 1956. Studies on the mechanism of serotonin-release by reserpine. Federation Proc. 15: 483. 46 Hess, S. M., P. A. Shore & B. B. Brodie 1956. Persistence of reserpine action after its disappearance from brain. Federation Proc. 16: 437. 47 Evarts, E. 1956. Some effects of bufotenin and lysergic acid diethylamide on the monkey. Arch. Neurol. Psychiat. 75: 49. 48 Stromberg, V. L. 1954. The isolation of bufotenin from Piptadenia peregrina. J. Am. Chem. Soc. 76: 1707. 49 Udenfriend, S., D. F. Bogdanski & H. Weissbach 1956. Increase in tissue serotonin by administration of its precursor, 5-hydroxytryptophan. Federation Proc. 15: 493. 50 Kuntzman, R., S. Udenfriend, E. G. Tomich, B. B. Brodie & P. A. Shore 1956. Biochemical effect of reserpine on serotonin binding sites. Federation Proc. 15: 450. Citing Literature Volume66, Issue3The Pharmacology of Psychotomimetic and Psychotherapeutic DrugsMarch 1957Pages 445-458 ReferencesRelatedInformation